icon-    folder.gif   Conference Reports for NATAP  
 
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
 
 
 
Renal and Bone Safety of Tenofovir Alafenamide
vs Tenofovir Disoproxil Fumarate
 
 
  Combined Safety Results of Studies GS-US-292-0104 and GS-US-292-0111
 
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
 
Webcast http://www.croiwebcasts.org/console/player/25797?mediaType=slideVideo&
 
Paul Sax1, Michael Saag2, Michael Yin3, Frank Post4, Shinichi Oka5, Ellen Koenig6, Benoit Trottier7, Jaime Andrade-Villanueva8,
Huyen Cao9, Marshall Fordyce9
1Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 2University of Alabama Birmingham, Birmingham, AL; 3College of Physicians and Surgeons, Columbia University, New York, NY; 4King's College, London, UK; 5National Center for Global Health and Medicine, Tokyo, Japan; 6Dominican Institute for Virologic Studies, Santo Domingo, Dominican Republic; 7Clinique Medicale L'Actuale in Montreal, Montreal, Canada; 8Unidad de VIH del Hospital Civil de Guadalajara, Guadalajara, Mexico; 9Gilead Sciences, Foster City, CA

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif

CROI9.gif

CROI10.gif